Billiontoone

BillionToOne is a publicly traded molecular diagnostics company that develops noninvasive prenatal screening tests (Unity Complete, Unity Confirm) and a liquid biopsy cancer test (Northstar) using its proprietary cell-free DNA molecular counting technology. The company has grown from launch to over $400M in annualized revenue in six years and employs 700+ people across California, with a new lab planned in Austin, TX.